BLUE SAIL MEDICAL released its performance for the first half of the year, with a net loss attributable to the parent company of 135 million yuan, narrowing by 15.88%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, BLUE SAIL MEDICAL released its semi-annual report for 2025, showing an operating income of 2.781 billion yuan, a year-on-year decrease of 7.49%. The net loss attributable to shareholders of the listed company was 135 million yuan, a year-on-year narrowing of 15.88%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 210 million yuan, a year-on-year increase of 11.82%. The basic loss per share was 0.13 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments